Hatching status before embryo transfer is not correlated with implantation rate in chromosomally screened blastocysts.

STUDY QUESTION Do the reproductive outcomes from the transfer of fully hatched (FH) blastocysts differ from those of not fully hatched (NFH) blastocysts? SUMMARY ANSWER Biochemical pregnancy rate (BPR), implantation rate (IR), live birth rate (LBR) and early pregnancy loss (EPL) rate are similar in FH and NFH single euploid blastocyst embryo transfers. WHAT IS KNOWN ALREADY The use of extended culture and PGS often leads to transfer of an embryo that is well developed and frequently FH from the zona pellucida. Without the protection of the zona, an FH embryo could be vulnerable to trauma during the transfer procedure. To date, no other study has evaluated the reproductive competence of an FH blastocyst transfer. STUDY DESIGN, SIZE, DURATION The retrospective study included 808 patients who underwent 808 cycles performed between September 2013 and July 2015 at a private academic IVF center. Of these, 436 cycles entailed transfer of a NFH blastocyst (n = 123 fresh transfer, n = 313 frozen/thawed embryo transfer (FET)) and 372 cycles entailed transfer of an FH blastocyst (n = 132 fresh, 240 FET). Fresh and FET cycles and associated clinical outcomes were considered separately. LBR was defined as the delivery of a live infant after 24 weeks of gestation. PARTICIPANTS/MATERIALS, SETTING, METHOD Trophectoderm biopsies were performed on Day 5 (d5) or 6 (d6) for embryos meeting morphology eligibility criteria (set at ≥3BC). Morphologic grading was determined using a modified Gardner-Schoolcraft scale prior to transfer. A single euploid embryo was selected for transfer per cycle on either the morning of d6, for fresh transfers or 5 days after progesterone supplementation for patients with transfer in an FET cycle. Embryos were classified as NFH (expansion Grade 3, 4 or 5) or FH (expansion Grade 6) cohorts. The main outcome measure was IR. MAIN RESULTS AND THE ROLE OF CHANCE In the fresh transfer group, IR was similar between NFH and FH cycles (53.7% versus 55.3%, P = 0.99, odds ratio (OR) 0.9; 95% confidence interval (CI) 0.6-1.5). Secondary outcomes were also statistically similar between groups: BPR (65.9% versus 66.7%, OR 1.0; 95% CI: 0.6-1.6), LBR (43.1% versus 47.7%, P = 0.45, OR 1.2; 95% CI: 0.7-1.9) and EPL rate (22.8% versus 18.2%, OR 1.3; 95% CI: 0.7-2.4). After adjusting for age, BMI, endometrial thickness at the LH surge and oocytes retrieved in a logistic regression (LR) model, the hatching status remained not associated with IR (P > 0.05). In the FET cycles, IR was similar between NFH and FH cycles (62.6% versus 61.7%, OR 1.0; 95% CI: 0.7-1.5). Secondary outcomes were similar between groups: BPR (74.1% versus 72.9%, respectively, OR 1.1; 95% CI: 0.7-1.6), LBR (55.0% versus 50.0%, OR 0.8; 95% CI: 0.6-1.1) and EPL rate (18.9% versus 22.9%, respectively, OR 0.8; 95% CI: 0.5-1.2). After adjusting for age, BMI, endometrial thickness at the LH surge and oocytes retrieved in an LR model, the hatching status was not shown to be associated with implantation (P > 0.05). LIMITATIONS, REASONS FOR CAUTION Limitations include the retrospective design and data from a single institution. Additionally, the study was limited to patients that developed high-quality blastocysts suitable for biopsy. WIDER IMPLICATIONS OF THE FINDINGS The results suggest that FH embryos are not more fragile or less likely to implant when compared to NFH counterparts. We found no evidence of altered IR or other clinical outcomes in the transfer of FH euploid embryos. STUDY FUNDING/COMPETING INTERESTS JG is funded by MSTP grant T32 GM007280 (NIH). No additional funding was received. There are no conflicts of interest to declare..

[1]  C. Farquhar,et al.  Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. , 2016, The Cochrane database of systematic reviews.

[2]  T. Mukherjee,et al.  Reproductive outcome is optimized by genomic embryo screening, vitrification, and subsequent transfer into a prepared synchronous endometrium , 2016, Journal of Assisted Reproduction and Genetics.

[3]  N. Treff,et al.  24-chromosome PCR for aneuploidy screening , 2015, Current opinion in obstetrics & gynecology.

[4]  Deanne Taylor,et al.  Clinically recognizable error rate after the transfer of comprehensive chromosomal screened euploid embryos is low. , 2014, Fertility and sterility.

[5]  E. Moshier,et al.  Blastulation rates decline in a linear fashion from euploid to aneuploid embryos with single versus multiple chromosomal errors. , 2014, Fertility and sterility.

[6]  D. Griffin,et al.  The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans. , 2014, Human reproduction update.

[7]  N. Treff,et al.  The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. , 2014, Fertility and sterility.

[8]  L. Regan,et al.  Unexplained recurrent pregnancy loss. , 2014, Obstetrics and gynecology clinics of North America.

[9]  Deanne M. Taylor,et al.  Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. , 2013, Fertility and sterility.

[10]  A. Copperman,et al.  Morphologic assessment of human blastocyst on day 5 and day 6: which day is more associated with comprehensive chromosome screening results? , 2013 .

[11]  D. Wells,et al.  The origin and impact of embryonic aneuploidy , 2013, Human Genetics.

[12]  W. Barfield,et al.  Assisted reproductive technology surveillance--United States, 2009. , 2012, Morbidity and mortality weekly report. Surveillance summaries.

[13]  J. Remohi,et al.  Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3,150 warming cycles. , 2012, Fertility and sterility.

[14]  G. Ambartsumyan,et al.  The effect of timing of embryonic progression on chromosomal abnormality. , 2012, Fertility and sterility.

[15]  D. Gook,et al.  A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. , 2012, Human reproduction update.

[16]  Deanne M. Taylor,et al.  Development and validation of an accurate quantitative real-time polymerase chain reaction-based assay for human blastocyst comprehensive chromosomal aneuploidy screening. , 2012, Fertility and sterility.

[17]  H. Nakagawa,et al.  Time-lapse videomicrographic observations of blastocyst hatching in cattle. , 2010, The Journal of reproduction and development.

[18]  B. V. Van Voorhis,et al.  Clinical predictors of human blastocyst formation and pregnancy after extended embryo culture and transfer. , 2010, Fertility and sterility.

[19]  A. Copperman,et al.  Human blastocyst morphological quality is significantly improved in embryos classified as fast on day 3 (>or=10 cells), bringing into question current embryological dogma. , 2008, Fertility and sterility.

[20]  Z. Nagy,et al.  Comparison of laser-assisted hatching and acidified Tyrode's hatching by evaluation of blastocyst development rates in sibling embryos: a prospective randomized trial. , 2006, Fertility and sterility.

[21]  O. Christiansen Evidence-based investigations and treatments of recurrent pregnancy loss. , 2005, Current opinion in obstetrics & gynecology.

[22]  M. Kinutani,et al.  Blastocoele collapse by micropipetting prior to vitrification gives excellent survival and pregnancy outcomes for human day 5 and 6 expanded blastocysts. , 2004, Human reproduction.

[23]  W. Son,et al.  An improved protocol for dilution of cryoprotectants from vitrified human blastocysts. , 2002, Human reproduction.

[24]  M. Montag,et al.  Significance of the Number of Embryonic Cells and the State of the Zona Pellucida for Hatching of Mouse Blastocysts In Vitro Versus In Vivo , 2000, Biology of reproduction.

[25]  K. Edashige,et al.  Cryopreservation of zona-hatched mouse blastocysts. , 1996, Journal of reproduction and fertility.

[26]  B. Bavister,et al.  Zona pellucida escape by hamster blastocysts in vitro is delayed and morphologically different compared with zona escape in vivo. , 1995, Biology of reproduction.

[27]  Z. Rosenwaks,et al.  Implantation enhancement by selective assisted hatching using zona drilling of human embryos with poor prognosis. , 1992, Human reproduction.

[28]  C. Hanzen,et al.  The behaviour of cow blastocyst in vitro: cinematographic and morphometric analysis. , 1982, Journal of anatomy.

[29]  G. Anderson,et al.  Blastocyst expansion and hatching of bovine ova cultured in vitro. , 1976, Journal of animal science.

[30]  R. Cole,et al.  Cinemicrographic observations on the trophoblast and zona pellucida of the mouse blastocyst. , 1967, Journal of embryology and experimental morphology.

[31]  Role of assisted hatching in in vitro fertilization: a guideline. , 2014, Fertility and sterility.

[32]  S. Daneshmand,et al.  Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony. , 2008, Fertility and sterility.

[33]  W. Son,et al.  Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. , 2003, Human reproduction.

[34]  M. Plachot The blastocyst. , 2000, Human reproduction.

[35]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.

[36]  Dk Gardner,et al.  In-vitro culture of human blastocysts , 1999 .

[37]  D. Gardner,et al.  Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. , 1998, Fertility and sterility.